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Precise control of cell physiology with high spatial and tempo-
ral resolution is in high demand in basic studies and biomedi-
cal applications. One of the several existing approaches to this
problem—optical control of protein activity and protein–
protein interactions with genetically encoded constructs (also
referred as non-opsin optogenetics)—looks promising because
of robust performance and high resulting precision.[1] A variety
of proteins naturally sensitive to light was used to develop the
tools for such optical manipulation. Small and structurally well-
characterized light-oxygen-voltage-sensing (LOV) domains
were widely used for the design of optogenetic tools based on
homodimerization, heterodimerization, and structural rear-
rangements (caging–uncaging). Examples of biological applica-
tions of LOV domain-based tools include regulation of protein
localization,[2] transcription activation in cells and animals,[3, 4]
and control of receptor activity.[5] Similar schemes were imple-
mented by using blue-light-using FAD (BLUF) domains and
cryptochromes. For instance, cryptochrome-derived hetero-
dimerizers Cry2 and CIB were used for Cre recombinase-regu-
lated gene expression.[6] Although successfully used in many
promising applications, all of these tools sense blue light, thus
limiting their compatibility with popular probes for visualiza-
tion and optical control excited within the same blue-green
spectral range.
Unlike blue-light-sensing LOV and BLUF domains and crypto-
chromes, phytochromes are proteins absorbing light within
the far red to near-infrared (NIR) spectral regions. Phytochrome
from Arabidopsis, PhyB, along with its interacting partners, was
used for the development of optogenetic tools based on light-
controlled heterodimerization. It was applied for transcription
activation,[7] manipulation of cell morphology,[8] and precise
protein targeting in living fish embryos.[9] As it is derived from
a plant, PhyB requires phycocyanobilin for functioning, which
is not produced by animal cells and therefore must be added
exogenously or synthesized within the cells by additionally
overexpressed enzymes.
Recently, several optogenetic systems were developed by
using bacterial phytochromes as templates. Bacterial phyto-
chromes incorporate biliverdin (BV) as a chromophore. BV is
found in mammalian cells as a product of heme degradation,
and, therefore, bacterial phytochromes work in most animal
cells without additional non-native chemical compounds. A
bacterial phytochrome from Rhodopseudomonas palustris,
RpBphP1 (hereafter BphP1), was used for light-controlled cell
signaling manipulation and transcription activation.[10] Subse-
quently, the engineered version of its interacting partner,
PpsR2 (termed QPAS1), was used to design the dual-color (NIR
and blue) light-sensing system for control of protein localiza-
tion (iRIS).[11]
Although a vast number of non-opsin optogenetic tools
exist, with applications in mammalian cells and whole body
applications,[12] their performance can vary dramatically in dif-
ferent cell types.[7] At the same time, the applicability of the
Near-infrared (NIR) light-inducible binding of bacterial phyto-
chrome BphP1 to its engineered partner, QPAS1, is used for
optical protein regulation in mammalian cells. However, there
are no data on the application of the BphP1–QPAS1 pair in
cells derived from various mammalian tissues. Here, we tested
the functionality of two BphP1–QPAS1-based optogenetic
tools—an NIR- and blue-light-sensing system for control of
protein localization (iRIS) and an NIR light-sensing system for
transcription activation (TA)—in several cell types, including
cortical neurons. We found that the performance of these op-
togenetic tools often relied on physiological properties of a
specific cell type, such as nuclear transport, which could limit
the applicability of the blue-light-sensitive component of iRIS.
In contrast, the NIR-light-sensing component of iRIS performed
well in all tested cell types. The TA system showed the best
performance in cervical cancer (HeLa), bone cancer (U-2 OS),
and human embryonic kidney (HEK-293) cells. The small size of
the QPAS1 component allowed the design of adeno-associated
virus (AAV) particles, which were applied to deliver the TA
system to neurons.
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tool to a certain experimental model relies strongly on specific
features of cell physiology.
To explore this issue, in this study, we tested the per-
formance of a BphP1–QPAS1 optogenetic system in mammali-
an cells of different origins, including neuroblasts and primary
neurons. To analyze the protein transport machinery, which is
crucial for the functionality of intracellular localization of
optical controllers, we utilized a tool combining BphP1 and
AsLOV2, called iRIS. Then we tested the BphP1–QPAS1 system
for the ability to activate transcription in the same cells. Lastly,
we took advantage of the small size of QPAS1 to address the
problem of optogenetic system delivery to the neuronal cells.
For this, we used adeno-associated viruses (AAVs) to deliver
the BphP1–QPAS1 system for gene regulation to activate the
transcription in primary neurons.
Results
Optical control of protein localization
To assess the functionality of a BphP1–QPAS1-based system in
protein targeting applications, a series of mammalian cells of
different origins were transfected with an iRIS construct
(Figure 1). In the NIR-light-controlled component of iRIS, a
CAAX motif (-CVIM) is utilized to target the protein of interest
to the plasma membrane. In the blue-light-controlled compo-
nent, nuclear localization of the protein of interest is achieved
by the balanced action of nuclear localization (c-Myc NLS) and
nuclear exclusion signals (Smad4 NES). An mCherry tag is used
for visualization.
As observed by epifluorescence microscopy, in darkness, the
iRIS-controlled protein was localized in the cytoplasm, showing
slightly lower fluorescence intensity in the nucleus (Figure 2).
Under NIR light of 740 nm (1 mW cm@2), all tested cell types
showed robust protein relocalization from the cytoplasm to
the plasma membrane, where it decorated cell periphery and
filopodia (Figure 2, Figure S1 in the Supporting Information).
Under blue light of 460 nm (1 mW cm@2), the nuclear accumu-
lation of mCherry was observed in all cell types studied, except
neurons and neuroblastoma-derived Neuro-2a cells. In Neuro-
2a cells, under blue illumination, the protein of interest was
observed on the plasma membrane, decorating the neurites,
and in juxtanuclear compartments, which presumably repre-
sented aggresomes.[13] Interestingly, another neuroblastoma-
derived cell line, SH-SY5Y, showed normal nuclear mCherry lo-
calization under blue light. In rat primary cortical neurons, simi-
larly to Neuro-2a, mCherry fluorescence decreased in the cyto-
plasm under blue light, but no nuclear fluorescence was ob-
served. In some cell types, such as HEK-293 human embryonic
kidney cells (Figure 2, bottom panel) under 460 nm illumina-
tion, a considerable amount of protein was observed in the
plasma membrane. Likely, this was caused by a rather high iRIS
Figure 1. Schematic representation of light-controllable protein targeting by using the NIR blue-light-inducible shuttle (iRIS). In cells transfected with iRIS,
under 740 nm light, NES-mCherry-QPAS1-AsLOV2cNLS is relocalized to plasma membrane-bound BphP1-mVenus (NIR light-controlled component). Under
460 nm light, the same construct is relocalized to nucleus, due to uncaged nuclear localization signal in AsLOV2 (blue-light-controlled component). Localiza-
tion of protein of interest is shown in red.
Figure 2. Tri-directional protein targeting in living mammalian cells transfected with iRIS, controlled with 740 nm and 460 nm light. Under 740 nm illumina-
tion, the protein is observed on the plasma membrane; under 460 nm light, the protein is expected to be localized in the nucleus. Scale bar: 10 mm.
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expression level and should be corrected either by reducing
the amount of plasmid used in transfection or by using a
weaker promoter for iRIS expression.
Quantification of fluorescence intensity showed a 35–50 %
signal decrease in the cytoplasm upon 740 nm light in all stud-
ied cell types (Figure 3 A), which reflects the cytoplasm-to-
membrane relocalization.[11] In accordance with visual observa-
tions, quantitative analysis of mCherry distribution under
460 nm showed no significant increase in the nucleus-to-cyto-
plasm ratio in Neuro-2a neuroblasts and an insignificant in-
crease (up to a 1.1:1 ratio) in primary neurons, whereas the
other cell types showed a 1.3–1.5-fold increase (Figure 3 B).
To further characterize the system for light-controlled subcel-
lular protein targeting, we tested how long iRIS could continue
to cause protein relocalization. As the reversibility of the LOV-
based part of iRIS was previously characterized,[3] we per-
formed time-lapse imaging under NIR illumination, followed by
thermal relaxation in the darkness, in sequential cycles. To ach-
ieve the maximal number of cycles within a time-lapse imaging
session of reasonable duration, duration of 740 nm illumination
was reduced to 5 min, which led to about a 20 % decrease in
the fluorescence level in the cytoplasm, whereas longer incu-
bation caused a 40 % decrease in epifluorescence microscopy.
We found that at least seven cycles of iRIS relocalization from
cytoplasm to the plasma membrane could be performed (Fig-
ure 3 C).
In addition to epifluorescence microscopy, we employed
confocal imaging to better characterize iRIS protein targeting
of the plasma membrane. When imaged by epifluorescence
microscopy, signal from the membrane is often mixed with the
unspecific signal from the neighboring cellular environment.
Moreover, blurred signal from the membrane, especially from
filopodia, can appear in the cytoplasm, sometimes barely dis-
tinguishable from protein aggregates. Confocal microscopy en-
ables avoiding of these effects, providing clear images of a par-
ticular optical section. In confocal images of HeLa cells express-
ing iRIS, after 10 min of light of 740 nm, a cell perimeter was
clearly visible and highlighted with signals from filopodia (Fig-
ure 4 A). The cytoplasm showed an even distribution of mCher-
ry signal, which was approximately 60 % lower than signal
Figure 3. Change in mCherry fluorescence levels of iRIS in different compartments under 740 nm and 460 nm illumination. A) mCherry fluorescence levels of
iRIS as measured in the cytoplasm in the dark (gray) and after 10 min of illumination at 740 nm (pink). Error bars represent S.E.M., n = 5 cells for each bar.
B) Nucleus-to-cytoplasm ratio of mCherry fluorescence of iRIS in the dark (gray) and after 10 min illumination at 460 nm (cyan). Error bars represent S.E.M. ,
n = 5 cells for each bar. C) mCherry fluorescence levels of iRIS as measured in the cytoplasm of HeLa cells in cycles of 5 min illumination at 740 nm, followed
by 20 min incubation in the dark. Error bars represent S.E.M., n = 5 cells for each bar. Images were acquired with an epifluorescence microscope.
Figure 4. NIR-light-driven relocalization of the iRIS protein, imaged with confocal microscopy. A) HeLa cells expressing iRIS. Scale bar: 10 mm. Dashed line
marks the region used for profile plotting. B) Intensity profiles of mCherry fluorescence in cells shown in panel A. C) Cortical neuron expressing iRIS. An aster-
isk marks the neuron body, and the inset shows the body enlarged. Scale bar: 10 mm. Dashed line marks the region used for profile plotting. D) Intensity pro-
files of mCherry fluorescence in cell shown in panel C.
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from the plasma membrane after illumination (Figure 4 B). Simi-
larly, in primary cortical neurons expressing iRIS, under 740 nm
light, mCherry signal was localized at the cell perimeter (Fig-
ure 4 C). In fluorescence intensity profiles, the plasma mem-
brane appeared as sharp peaks, with a decrease in cytoplasmic
fluorescence of about 50 % compared to the intensity at the
plasma membrane (Figure 4 D).
Together, these data suggest that the BphP1–QPAS1 pair can
be used in all tested cell types, including neurons. However,
further optimization of the blue-light-sensing part of the iRIS
system is needed to efficiently work in neuronal cells.
Light-controlled transcription regulation
We further analyzed the performance of the BphP1–QPAS1 op-
togenetic pair as applied to transcription control in different
mammalian cell types. For this, a set of cells corresponding to
those tested with iRIS was cotransfected with pQP-T2A plasmid
and luciferase reporter, controlled by GAL4 upstream activation
signal sequences (GAL4-UAS) (Figure 5). The pQP-T2A plasmid
encodes BphP1 fused to a VP16 transactivator and QPAS1
fused to a GAL4 DNA-binding domain and tagged with SV40
NLS (PKKKRK). Under NIR illumination, the GAL4 DNA-binding
domain and VP16 transactivator associate due to light-induced
BphP1–QPAS1 interaction. Being in the nucleus, reconstituted
transcription factor drives the expression of the GAL4-UAS-con-
trolled reporter gene.
Most of the tested cell lines showed several-fold elevation in
luciferase signal under NIR light, as compared to signal in dark-
ness (Figure 6). The highest light-to-dark contrast was ob-
served in HeLa, HEK-293, and U2 OS cells (28.0-, 8.9-, and 6.1-
fold, respectively). Lower light-to-dark contrast was observed
in COS-7, SH-SY5Y, and Neuro-2A cells, which was in accord-
ance with data on optical control of protein targeting (Fig-
ure 3 B), as transcription activation partly depends on relocali-
zation of the BphP1–VP16 and NLS–GAL4–QPAS1 complexes,
driven by nuclear localization signal.
Viral gene delivery of the BphP1–QPAS1 system to neurons
Primary cell cultures are often considered hard to transfect,[14]
and primary hippocampal and cortical neurons are sometimes
considered some of the most difficult targets for gene trans-
fer.[15] Electrical transfection methods are reported to irreversi-
bly affect cellular physiology and reduce neuron viability;
chemical transfection methods (such as calcium phosphate
transfection and lipofection) usually provide low transfection
efficiency, especially in non-dividing cultures.[16] To overcome
these limitations, we decided to use a viral system for the de-
livery of the BphP1–QPAS1 pair to primary neuronal cultures.
We chose adeno-associated virus (AAV) serotype 9 because
it was shown that this serotype effectively and specifically
transduces neurons in mice[17] and rats.[18] As mammalian pro-
moters are advantageous in some cases compared to viral pro-
moters,[19] we decided to use the CaMKII promoter to drive
BphP1–QPAS1 expression in neurons. The shortened WPRE–
PolyA expression cassette,[20] the small size (519 bp) of QPAS1,
and the general optimization of vector architecture[11] allowed
us to pack the whole BphP1–QPAS1 system (3684 bp) for tran-
scription activation into a single AAV vector (Figure 7 A). A
Figure 5. Schematic representation of light-controllable gene transcription
activation. The BphP1–VP16 fusion is localized in the cytoplasm in the dark.
Under NIR light, it interacts with QPAS1 fused to the GAL4 DNA-binding
domain. The complex is transported to the nucleus because of the presence
of nuclear localization signal in the QPAS1–GAL4 construct, leading to activa-
tion of reporter gene expression (highlighted in green).
Figure 6. Change in luciferase expression under NIR light in mammalian cells
of different origin cotransfected with pQP-T2A and luciferase reporter plas-
mids. Cells were kept in darkness or under 740 nm illumination. For each
cell type, the luciferase induction level was normalized to the level of cells
kept in darkness. Error bars represent S.E.M., n = 3. Luciferase levels for cells
kept in darkness, cells illuminated with light at 740 nm, and cells transfected
with reporter construct only can be found in Figure S2.
Figure 7. Viral gene delivery of the BphP1–QPAS1 system for transcription
activation to primary cortical neurons. A) Constructs used for AAV produc-
tion. B) Luciferase expression level in neurons transduced with AAV carrying
constructs shown in A) and kept in darkness and under 740 nm light. Error
bars represent S.E.M. , n = 3.
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UAS-driven luciferase reporter, with junk DNA added to reach
the optimal length for AAV packaging, was delivered in sepa-
rate AAV particles. In transduced primary rat cortical neurons,
the luciferase signal was 2.5-fold higher under NIR light than in
darkness (Figure 7 B). Thus, we were able to apply, for the first
time, an AAV gene transfer system for delivery of a bacterial
phytochrome-based optogenetic system to primary neurons.
Among viral gene delivery approaches, AAV-based systems are
generally regarded as superior for neuronal cultures because
of low toxicity, high efficiency, and safety.[21]
Discussion
In this study, we tested the applicability of optogenetic sys-
tems for protein targeting (iRIS) and transcription activation
(TA), developed from a bacterial phytochrome, to mammalian
cells of different origins. We found that the performance of
BphP1–QPAS1-based systems varied significantly in different
cells (Table 1). Particularly, in experiments with iRIS, poor effi-
ciency of cytoplasm-to-nucleus relocalization was observed
under blue light in Neuro-2A cells and in neurons. This shifted
NLS/NES equilibrium in neuroblasts and neurons can be ex-
plained by differences in the active nuclear transport mecha-
nisms between cells of neuronal and non-neuronal origins. In
non-neuronal cells, in the cytoplasm, proteins carrying an NLS
sequence bind importin-b and importin-a complexes. After
transition through the nuclear pore, NLS-tagged proteins are
released in the nucleus, and the importins are recycled.[22] In
contrast, in cells of neuronal origin, due to their polar pheno-
type, importins are involved not only in cytoplasm-to-nucleus
transport but also in synapse-to-nucleus signaling.[23, 24] Thus,
nuclear import machinery components are distributed in the
cell in a different way, being localized not only in somal parts
and the nucleus but also in neurites and partly immobilized by
cytoskeleton.[25, 26]
The TA system also showed remarkably varied results among
the tested cells ; this was in accordance with studies of other
chemically[27] and optically[7, 28] controlled systems tested in dif-
ferent cell types. Notably, the performance of the TA system
depended not only on transcription factor cellular localization,
controlled by nuclear import machinery, but also on the
BphP1–QPAS1 interaction, which added an additional level of
control to the system. In the dark, dissociated GAL4 and VP16
do not activate transcription. This might explain the available
increase in reporter expression, despite the reduced relocaliza-
tion functionality in certain cell types. Performance of the
BphP1–QPAS1 pair in both described applications could be
improved by further engineering of BphP1, aimed at reducing
undesirable binding of QPAS1 in the dark. For this, similar to
other light-sensing proteins,[12] directed molecular evolution
and structure-based protein engineering of BphP1 could be
used.
Our data suggested that the NIR protein targeting and TA
systems could be used in various cell types; however, they re-
quire additional adjustment for neuroblastoma cells and neu-
rons. Although a considerable number of optically controlled
tools have been proposed to study neuronal functions,[29] the
NIR-light-controlled tools are represented rather poorly in neu-
roscience. We anticipate that our results will be a starting
point for further development and use of BphP1-based sys-
tems in neuronal tissues. Together with the NIR fluorescent
proteins used for advanced imaging in neurons,[30–32] NIR opto-
genetic tools should be superior for multiplexing with blue/
green-light-sensing constructs, including opsin-based actuators
and inhibitors.
Experimental Section
Mammalian cell culture: Human epithelioid cervix carcinoma
(HeLa) cells, human bone osteosarcoma epithelial cells (U-2 OS),
human embryonic kidney cells (HEK-293), African green monkey
fibroblast-like cells (COS-7), human bone marrow neuroblastoma
cells (SH-SY5Y), mouse neuroblastoma cells (Neuro-2a), and mouse
embryonic fibroblast cells (NIH/3T3) were maintained in Dulbecco’s
modified Eagle’s medium (DMEM; Gibco) supplemented with 10 %
fetal bovine serum (FBS; Gibco) and antibiotic–antimycotic (Gibco).
Effectene transfection reagent (Qiagen) was used for transfection.
The culture medium was changed 6 h after transfection with a
new one containing biliverdin (BV; 25 mm).
Cell light activation and imaging: Epifluorescence microscopy
was performed by using an Olympus IX83 equipped with a 200 W
Table 1. Performance of the BphP1–QPAS1-based iRIS and TA optogenetic systems in cells of different origin.
Cell type Organism Tissue Disease iRIS TA
Change under Change in nucleus/cytoplasm Light-to-dark signal
740 nm [%][a] ratio under 460 nm[b] ratio under 740 nm[c]
HeLa Homo sapiens cervix adenocarcinoma 39 0.48 28.0
U-2 OS H. sapiens bone osteosarcoma 49 0.43 6.1
HEK-293 H. sapiens kidney normal condition 45 0.49 8.9
COS-7 Cercopithecus aethiops kidney SV40 transformed 46 0.43 2.6
SH-SY5Y H. sapiens bone marrow neuroblastoma 36 0.33 3.0
Neuro-2a Mus musculus brain neuroblastoma 29 0.05 2.5
Primary cortical neurons Rattus norvegicus brain, cortex normal condition 53 0.29 2.5[d]
[a] Percent decrease in mCherry fluorescence in the cytoplasm as a result of protein relocalization from cytoplasm to plasma membrane; indicates the
performance of NIR-sensitive component of iRIS. [b] Change in nucleus-to-cytoplasm signal ratio as a result of protein relocalization from cytoplasm to
nucleus; indicates the performance of blue-sensitive component of iRIS. [c] Light-to-dark signal ratio in cells transfected with pQP-T2A plasmid for TA,
measured by luciferase assay. [d] Detected in primary neurons transduced with AAV particles carrying the TA system.
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metal halide arc lamp (Lumen 220PRO, Prior) and an optiMOS
sCMOS camera (QImaging). Cells transfected with pQP-iRIS[11]
(Addgene #102584) were imaged by using a 60 V , 1.35 NA oil ob-
jective lens (UPlanSApo, Olympus). During imaging, cells were kept
in live cell imaging solution (Life Technologies–Invitrogen) at 37 8C.
The data were analyzed by using SlideBook (v. 6.0.8; 3i), and
ImageJ (v. 1.50b) software.[33] For the relocalization assay, blue and
NIR illumination was applied by using the 460/20 nm and 740/
25 nm custom-assembled LED arrays (LED Engin), respectively.
First, cells were illuminated for 10 min with 740/25 nm LED
(1 mW cm@2), then, after 30 min in darkness for relaxation, the dish
was illuminated with 460/20 nm LED (1 mW cm@2). Focusing of the
microscope was performed in an mCherry excitation channel to
prevent unspecific activation of blue- and NIR-light-sensing com-
ponents. CELLview glass-bottomed dishes (Greiner Bio-One) were
used for imaging. Confocal imaging was performed by using a
Leica TCS SP8 X microscope equipped with a 63 V , NA 1.4 and HC
PL APO CS2 objective and a white light laser (470–670 nm).
After image acquisition, the images were analyzed by using Fiji
software (v. 1.50b).[34] First, the background fluorescence was sub-
tracted. Then, five circular regions of interest (ROI) were placed
randomly in the cytoplasm and nuclei of the imaged cells while
avoiding aggregates, filopodia, and nucleoli. The mean fluores-
cence intensity was calculated for each ROI. After compensation
for photobleaching, the mean values were calculated for 5–10 cells
in each experimental group. The nucleus-to-cytoplasm ratio was
calculated for cells illuminated with 460 nm light, and normaliza-
tion to levels in the dark was performed for cells kept under
740 nm illumination. Data were plotted by using OriginPro (Origin
Labs; v. 8.6).
Firefly luciferase (Fluc) assay: For light-controlled transcription ac-
tivation, cells were cotransfected with the constructs pQP-T2A[11]
(Addgene #102583) and pFR-Luc (Agilent Technologies) in a 3:1
ratio in 24-well plates (Greiner Bio-One). Illumination of plates was
performed directly in a CO2 incubator with 740/25 nm light
(0.2 mW cm@2) in alternating cycles of 30 s light and 180 s darkness.
To measure Fluc activity, transfected cells were lysed 48 h after
transfection. Cells were washed with phosphate-buffered saline
(PBS), and lysis buffer (100 mL; 20 mm Tris·HCl, pH 8.0, 10 % glycer-
ol, 0.1 % b-mercaptoethanol, 0.1 % Triton X-100, 1 mm PMSF) was
added to each well of a 24-well plate and incubated on ice for
30 min. Cell lysates (10 mL) were mixed with firefly luciferase assay
reagent (20 mL, NanoLight Technology) in 96-well half-area white
plates (Costar). Bioluminescence signals were measured by using a
Victor X3 multilabel plate reader (PerkinElmer).
Neuronal culture and transfection: Primary rat neuronal cultures
were prepared at the Neuronal Cell Culture Unit at the University
of Helsinki. All animal work was performed in accordance with the
ethical guidelines of the European Convention and regulations of
the Ethics Committee for Animal Research of the University of Hel-
sinki. Dissociated cortical neurons were plated to 24-well plate at a
density of 105 cells per well, coated with poly-l-lysine (0.1 mg mL@1,
Sigma–Aldrich) in a neurobasal medium (Gibco), supplemented
with B27 (Life Technologies/Invitrogen), l-glutamine (Invitrogen),
and penicillin–streptomycin (Lonza). Neurons were transduced
after three days in vitro (DIV3); each AAV was used at a concentra-
tion of 109 genome copies per well. 740/25 nm illumination
(0.2 mW cm@2, in alternating cycles of 30 s light and 180 s darkness)
started on DIV6, and cells were lysed on DIV9 for the Fluc assay.
BV (25 mm) was added to the culture medium on DIV3. The Fluc
assay was performed as described above.
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